All News

Found 16,361 articles

• Drug Firms Make More Study Results Public

  12/29/2005

• The Day In Review: Alkermes And Cephalon, Inc. Alcohol Drug Gets Approvable Letter

  12/29/2005

• Novartis Pharma K.K. Files Applicaion Seeking Additional Indication For Glivec In Japan

  12/27/2005

• Anadys Pharmaceuticals, Inc. To Initiate 28-Day Clinical Trial Of ANA975 In Patients With Chronic Hepatitis C

  12/23/2005

• QLT Inc. Announces Departure Of Chief Business Officer

  12/22/2005

• Takeda Pharmaceutical Co. Ltd. And Abbott Laboratories Gives Novartis International AG U.S. OTC Prevacid Rights

  12/21/2005

• Sosei Co., Ltd., HRA, And Sandoz/Hexal Australia To Conclude Sublicensing Agreement For "Morning After Pill" SOH-075

  12/21/2005

• The Day In Review: MGI Pharma Inc. Surges On Trial News

  12/21/2005

• American BioScience, Inc. Names Barry Flannelly, Pharm.D, MBA, As Global Vice President Sales And Marketing - Abraxis Oncology

  12/21/2005

• Santhera Pharmaceuticals AG Raises CHF 25 Million Via A Further Closing Of Its 2005 B Financing Round

  12/20/2005

• Tanox, Inc. Submits Investigational New Drug Application For TNX-650 For Treatment Of Hodgkin's Lymphoma

  12/20/2005

• Anadys Pharmaceuticals, Inc. Announces Two Executive Advances

  12/20/2005

• Berna Biotech AG Shares Soar As Novartis (NVS) Considers Bid

  12/19/2005

• Data Indicates Tanox, Inc. HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses And Synergistic With Entry Inhibitor; Shares Jump On HIV Drug Promise

  12/19/2005

• MonoSolRx LLC Announces The Hiring Of Alexander Mark Schobel From Novartis Consumer Health, Inc. As Its New President And CEO, And The Relocation Of The Company's Headquarters To New Jersey

  12/19/2005

• The Day In Review: Novartis Corporation May Add To Vaccine Franchise

  12/19/2005

• Additional Phase 2 Data Supports Further Development Of Tanox, Inc.'s Novel HIV Therapy

  12/19/2005

• IVAX Corporation Receives Final Approval On Clozapine Tablet

  12/19/2005

• Novartis Pharmaceuticals Corporation Release: Single-Day Famvir Treatment Found To Shorten The Duration Of Recurrent Genital Herpes Outbreaks

  12/19/2005

• Novartis Corporation Halts Cholesterol Drug Development

  12/16/2005